HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nu Skin Enterprises

This article was originally published in The Rose Sheet

Executive Summary

First quarter sales of Nu Skin division jumped 26% to $132.4 mil., largely boosted by new product introductions and strong performance in China, company reports April 21. Among recent launches is Nu Skin Polishing Peel, which debuted in February (1"The Rose Sheet" Dec. 8, 2003, p. 8). Overall revenue grew 20% to $264 mil., driven by the firm's performance in China. Net income was up 13% to $14.5 mil. Nu Skin anticipates second quarter revenue will reach $270 mil.-$275 mil., and forecasts $1.1 bil.-$1.2 bil. in overall sales in fiscal 2004...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel